Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check7 days agoChange DetectedAdds a new CABOSUN trial publication reference to Publications, including author names. The previous Cabozantinib vs Sunitinib citation and its erratum details are removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a platform/version update without changing the underlying study information.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded: Cabozantinib Versus Sunitinib... CABOSUN Trial publication (Choueiri et al., J Clin Oncol 2017) with erratum and subsequent updates (v3.5.2). Deleted: the earlier CABOSUN JCO 2017 entry (v3.5.0).SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check72 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the previous Revision: v3.4.1 text and the government funding operating-status notice.SummaryDifference0.5%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.